OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Squadron Capital Llc Sells 16,300 Shares

Key Points

• Major shareholder Squadron Capital sold 16,300 OrthoPediatrics shares for $403,262 at an average price of $24.74, reducing its stake by 0.24% to 6.88 million shares. The firm also reported additional sales of 18,000 shares on August 26 and 4,000 shares on August 24.
• OrthoPediatrics shares fell 1.9% to $24.03, while the company reported quarterly revenue of $70.51 million and an adjusted loss of $0.26 per share—both better than analyst expectations.
• Analysts maintain a generally positive view, with nine Buy ratings, one Hold and one Sell; the stock has a “Moderate Buy” consensus rating and an average price target of $26.44.

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) major shareholder Squadron Capital Llc sold 16,300 shares of the company's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $24.74, for a total transaction of $403,262.00. Following the completion of the transaction, the insider owned 6,881,464 shares in the company, valued at approximately $170,247,419.36. The trade was a 0.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $25.75, for a total transaction of $103,000.00.

OrthoPediatrics Trading Down 1.9%

KIDS stock traded down $0.47 during mid-day trading on Wednesday, reaching $24.03. The company had a trading volume of 169,608 shares, compared to its average volume of 171,545. The company has a market capitalization of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. The firm has a 50 day moving average of $21.11 and a 200 day moving average of $18.53. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The firm had revenue of $70.51 million during the quarter, compared to analyst estimates of $68.21 million. On average, equities analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on KIDS. Truist Financial set a $22.00 price target on OrthoPediatrics in a research report on Wednesday, August 5th. Piper Sandler reaffirmed an "overweight" rating and issued a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, August 5th. TD Cowen reissued a "buy" rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Finally, BTIG Research boosted their price target on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a "buy" rating in a report on Thursday, August 20th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, OrthoPediatrics has an average rating of "Moderate Buy" and an average price target of $26.44.

Hedge Funds Weigh In On OrthoPediatrics

Large investors have recently added to or reduced their stakes in the company. Millennium Management LLC boosted its holdings in shares of OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company's stock valued at $24,802,000 after buying an additional 452,840 shares in the last quarter. BlackRock Inc. bought a new position in shares of OrthoPediatrics during the 2nd quarter worth approximately $24,347,000. Vanguard Group Inc. lifted its position in OrthoPediatrics by 1.1% during the third quarter. Vanguard Group Inc. now owns 961,330 shares of the company's stock valued at $17,813,000 after acquiring an additional 10,927 shares during the last quarter. Granahan Investment Management LLC lifted its position in OrthoPediatrics by 35.1% during the first quarter. Granahan Investment Management LLC now owns 896,741 shares of the company's stock valued at $14,231,000 after acquiring an additional 232,760 shares during the last quarter. Finally, Wasatch Advisors LP boosted its stake in OrthoPediatrics by 56.6% in the second quarter. Wasatch Advisors LP now owns 515,677 shares of the company's stock valued at $9,865,000 after acquiring an additional 186,357 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source